|
|
||
|
|
The Cardiovascular Division at University of Louisville School of Medicine is dedicated to providing exceptional and compassionate care to patients, and leading the field in basic and clinical cardiovascular research. Most importantly we are dedicated to shaping the minds of future generations of leaders in cardiovascular medicine. • The American Heart Association has reappointed Dr. Roberto Bolli to the prestigious editor post at Circulation Research. Read More. • “Incredible!” That’s how Mike Jones describes his life three and a half years after receiving stem cells as part of Dr. Roberto Bolli’s groundbreaking SCIPIO trial. The study, in which twenty patients received their own cardiac stem cells, has transformed Mike Jones’ life. Read more. • November, 2012: CSW News interviews UofL Cardiology chair Roberto Bolli, MD about the promising stem cell study SCIPIO. • $3.4 million NIH grant establishes cardiac clinical research center at UofL • The Division receives national attention after The Lancet publishes results of stem cell research at the Institute of Molecular Cardiology. Watch videos • The The PARTNER II clinical trial using a nonsurgical transcatheter approach to aortic valve replacement comes to UofL and Jewish Hospital with Dr. Michael Flaherty as the Co-principal investigator. • UofL awarded $9.56 million to form first-ever multi-center cardiovascular research network with the Division of Cardiology's Dr. Roberto Bolli as the principal investigator. Learn about CAESAR
|
|



